Home > Privacy Policy

MyIgSource Privacy Policy

I understand that the information I have provided will be used by Shire and its contracted third parties to contact me by mail, email, and phone with helpful information on Shire treatments and indicated conditions, as well as products and services. Shire may also review my program engagement and information with my or my child's physician in order to provide feedback regarding these services. Shire will not sell or transfer my name or contact information to any third party for their marketing use. The privacy policy in its entirety can be accessed here.

I understand that Shire collects the information because it is necessary to enable individuals to register for, customize and personalize certain aspects of Shire's programs, resources and communications. Shire uses the information to provide communications on its products and services including valuable resources and tools. Shire may also evaluate the use of these resources and communications with non-identifiable or aggregate information to better address patient needs in the future.

Personal information about you will be accessible to Shire and its subsidiaries, and to individuals and organizations that use personal information solely for and at the direction of Shire. Uses and disclosures of personal information by external individuals and organizations acting on Shire's behalf are governed by agreements that require personal information to be protected appropriately. This site does not seek to collect personal information from children under the age of 13 and will not retain this information if aware of its receipt.

Gammagard Liquid MyIgCoPayCard Program Terms and Conditions

This manufacturer's coupon program is not valid for prescriptions reimbursed, in whole or in part, by Medicaid, Medicare, Medigap, VA, DoD, TRICARE, or any other federal or state healthcare programs, including state pharmaceutical assistance programs, and where prohibited by the health insurance provider or by law

Shire's MyIgCoPayCard program provides a maximum total benefit of $5,000 for eligible out-of-pocket costs and expires 12 months from date of activation. Eligible costs include deductible, copayment, and co-insurance costs for eligible Shire IG (Immunoglobulin) products. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible.

To be eligible, patients must: 1. be starting or receiving treatment with (and have current prescription for) an eligible Shire IG product with an ICD-10 for a diagnosis of Primary Immunodeficiency; and 2. have commercial insurance that covers medication costs for prescribed Shire IG product and allows for CoPay assistance; and 3. be two (2) years old or older.

Acceptance of this offer must be consistent with the terms of benefits provided by patient's health insurance provider.

Offer limited to one card per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, or other offer.

This program is only valid for residents of the United States.

Shire reserves the right to change or discontinue this program at any time without notice.

This is not health insurance.


Add to patient instructions:

If your insurance situation changes, it is your responsibility to notify MyIgSource's CoPay assistance program.

© 2017 Shire. All rights reserved.

SHIRE and the Shire Logo are registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates. Gammagard Liquid is a trademark or registered trademark of Baxalta Incorporated, a wholly owned, indirect subsidiary of Shire plc.

S30515 04/17

Please expand for Indication and Important Safety Information.


What is the most important information that I should know about GAMMAGARD LIQUID?

GAMMAGARD LIQUID can cause the following serious reactions: severe allergic reactions causing difficulty in breathing or skin rashes; decreased kidney function or kidney failure; blood clots in the heart, brain, lungs or elsewhere in the body; severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting; dark colored urine, swelling, fatigue, or difficulty breathing.